He M - Search Results

1

Epigallocatechin-3-Gallate Attenuates Microglial Inflammation and Neurotoxicity by Suppressing the Activation of Canonical and Noncanonical Inflammasome via TLR4/NF-κB Pathway.

Zhong X, Liu M, Yao W, Du K, He M, Jin X, Jiao L, Ma G, Wei B, Wei M. Zhong X, et al. Among authors: he m. Mol Nutr Food Res. 2019 Nov;63(21):e1801230. doi: 10.1002/mnfr.201801230. Epub 2019 Aug 16. Mol Nutr Food Res. 2019. PMID: 31374144

2

Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.

Zhao L, Wang L, Jin F, Ma W, Ren J, Wen X, He M, Sun M, Tang H, Wei M. Zhao L, et al. Among authors: he m. Breast Cancer Res Treat. 2009 Sep;117(2):253-9. doi: 10.1007/s10549-008-0192-1. Epub 2008 Sep 24. Breast Cancer Res Treat. 2009. PMID: 18814026

3

Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose.

He M, Zhao L, Wei MJ, Yao WF, Zhao HS, Chen FJ. He M, et al. Biol Pharm Bull. 2009 Jan;32(1):55-60. doi: 10.1248/bpb.32.55. Biol Pharm Bull. 2009. PMID: 19122281 Free article.

4

Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.

Zhao L, Yu Z, Li Y, Wen X, Ma W, Wang L, Ren J, Liu C, He M, Bai X, Sun M, Zheng Z, Mi X, Wang E, Olopade OI, Jin F, Wei M. Zhao L, et al. Among authors: he m. Med Oncol. 2012 Sep;29(3):1569-75. doi: 10.1007/s12032-011-0107-6. Epub 2011 Nov 22. Med Oncol. 2012. PMID: 22105146

5

Reversing multidrug resistance by tyrosine kinase inhibitors.

He M, Wei MJ. He M, et al. Chin J Cancer. 2012 Mar;31(3):126-33. doi: 10.5732/cjc.011.10315. Epub 2012 Jan 9. Chin J Cancer. 2012. PMID: 22237041 Free PMC article. Review.

6

Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.

Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M. Li Y, et al. Among authors: he m. PLoS One. 2012;7(8):e44254. doi: 10.1371/journal.pone.0044254. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952942 Free PMC article.

7

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.

He M, Sun HG, Hao JY, Li YL, Yu JK, Yan YY, Zhao L, Li N, Wang Y, Bai XF, Yu ZJ, Zheng ZH, Mi XY, Wang EH, Wei MJ. He M, et al. Oncol Rep. 2013 May;29(5):1721-9. doi: 10.3892/or.2013.2295. Epub 2013 Feb 21. Oncol Rep. 2013. PMID: 23440494 Free PMC article.

8

[Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].

He M, Liu MY, Wang S, Tang QS, Yao WF, Zhao HS, Wei MJ. He M, et al. Zhong Yao Cai. 2012 Oct;35(10):1641-4. Zhong Yao Cai. 2012. PMID: 23627134 Chinese.

9

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).

Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M. Jiao X, et al. Among authors: he m. Breast Cancer Res Treat. 2013 Jun;139(3):717-30. doi: 10.1007/s10549-013-2607-x. Epub 2013 Jun 19. Breast Cancer Res Treat. 2013. PMID: 23780685

10

MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).

Ma MT, He M, Wang Y, Jiao XY, Zhao L, Bai XF, Yu ZJ, Wu HZ, Sun ML, Song ZG, Wei MJ. Ma MT, et al. Among authors: he m. Cancer Lett. 2013 Oct 1;339(1):107-15. doi: 10.1016/j.canlet.2013.07.016. Epub 2013 Jul 20. Cancer Lett. 2013. PMID: 23879965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,718 results

Search Page

Filters